comparemela.com

Latest Breaking News On - Craig hallum capital group - Page 1 : comparemela.com

Five Below (FIVE) Q1 2024 Earnings Call Transcript

FIVE earnings call for the period ending March 31, 2024.

United statesNorth carolinaBrad thomasJeremy hamblinKate mcshane goldman sachsWilliam dosset oppenheimerScot ciccarelli truistJohn heinbockelMichael montaniDavid bellinger mizuhoSimeon gutman morgan stanleyJoe feldmanEdward kellyDavid bellingerScot ciccarelliGordon haskett

DEFM14A: Definitive proxy statement - MarketScreener

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy.

United statesIdentiv ioJamese ousleySteven humphreysIntelligent software monitoringCompany internet of things ioOpinion of craig hallum capital groupBluetooth low energyParty beneficiariesTransition services agreementIdentiv privateExchange commissionExchange actCompany the physical security businessCompany ioCompany under delaware

Destination XL Group, Inc (NASDAQ:DXLG) Q1 2024 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Q1 2024 Destination XL Group Incorporated Earnings Call. At this time, all participants are in a listen-only mode.

New yorkUnited statesCoon rapidsThousand oaksShelly mokasJeremy hamblinRalph laurenHugo bossPeter strattonHarvey kanterMichael bakerCraig hallum capital groupExchange commissionDestination xl group incorporated earnings callDestination xl group first quarter fiscalDestination xl group inc

Stratasys (SSYS) Q1 2024 Earnings Call Transcript

SSYS earnings call for the period ending March 31, 2024.

Comunidad autonoma de catalunaYonah lloydDanny eggerichsYoav zeifAlek valeroTroy jensen cantor fitzgeraldWilliam blairAmir kleinerJim ricchiutiChris grenga needhamChris grengaEitan zamirTroy jensenDanny eggerichs craig hallum capital group analystCantor fitzgeraldCompany analyst

Applied DNA Sciences, Inc : Applied DNA Announces Pricing of $12 Million Public Offering

STONY BROOK, NY / ACCESSWIRE / May 28, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the pricing of a public

New yorkUnited statesStony brookSyndicate departmentLaidlaw company united kingdom ltdSciences incSecurities exchangeSpindle biotech incExchange commissionCraig hallum capital groupProduction servicesMdx testing servicesCommon shareSeriesb warrantPre funded warrantTesting services

vimarsana © 2020. All Rights Reserved.